The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes

Nielsen, Eva-Maria D.; Hansen, Lars; Carstensen, Bendix; Echwald, Søren M.; Drivsholm, Thomas; Glümer, Charlotte; Thorsteinsson, Birger; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf
February 2003
Diabetes;Feb2003, Vol. 52 Issue 2, p573
Academic Journal
The E23K polymorphism of the pancreatic β-cell ATPsensitive K[sup +] (K[sup ATP]) channel subunit Kir6.2 (KCNJ11) is associated with type 2 diabetes in whites, and a recent in vitro study of the E23K variant suggests that the association to diabetes might be explained by a slight inhibition of serum insulin release. In a study comprising 519 unrelated glucose-tolerant subjects, we addressed the question as to whether the E23K variant was related to reduced serum insulin release during an oral glucose tolerance test (OGTT). Furthermore, the polymorphism was examined in a case-control study comprising 803 type 2 diabetic patients and 862 glucosetolerant control subjects. The E23K variant was associated with significant reductions in the insulinogenic index (P = 0.022) and serum insulin levels under the response curve during an OGTT (0-120 min) (P = 0.014) as well as with an increase in BMI (P = 0.013). In the present study, the association of the E23K polymorphism with type 2 diabetes was not significant (P = 0.26). However, the K23K genotype significantly associated with type 2 diabetes in a meta-analysis of white case and control subjects (n = 2,824, odds ratio [OR] 1.49, P = 0.00022). In conclusion, the widespread E23K polymorphism may have a diabetogenic effect by impairing glucose-induced insulin release and increasing BMI.


Related Articles

  • Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus. Landgraf, R. // Drugs & Aging;2000, Vol. 17 Issue 5, p411 

    Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic β-cells to glucose is already markedly disturbed in the early stages of type 2...

  • Ethnic Differences in β-Cell Functional Reserve and Clinical Features in Patients With Ketosis-Prone Diabetes. Maldonado, Mario R.; Otiniano, Max E.; Lee, Rebekah; Rodriguez, Lucille; Balasubramanyam, Ashok // Diabetes Care;Aug2003, Vol. 26 Issue 8, p2469 

    Studies the ethnic differences in beta-cell functional reserve and clinical features in patients with ketosis-prone diabetes. Clinical and demographic characteristics of ketosis-prone indigent subjects; Results indicating that Hispanic patients are more likely to have better beta-cell reserve...

  • Murder mysteries in type 1 diabetes. Kaufman, Daniel L. // Nature Medicine;Feb2003, Vol. 9 Issue 2, p161 

    Discusses findings of a study that nervous system cells surrounding insulin-producing cells in the pancreas are destroyed early in the development of type 1 diabetes. Disease process; Prediagnostic markers and therapies; Onset of insulitis.

  • Altered Homeostatic Adaptation of First- and Second-Phase Î’-Cell Secretion in the Offspring of Patients With Type 2 Diabetes. Bonadonna, Riccardo C.; Stumvoll, Michael; Fritsche, Andreas; Muggeo, Michele; Häring, Hans; Bonora, Enzo; van Haeften, Timon W. // Diabetes;Feb2003, Vol. 52 Issue 2, p470 

    We adapted a minimal model to assess β-cell function during a hyperglycemic glucose clamp and to uncover peculiar aspects of the relationship among β-cell function, plasma glucose, and insulin sensitivity (IS) in offspring of Caucasian patients with type 2 diabetes (OfT2D). We pooled two...

  • Tolerance in autoimmunity and transplant immunology. Dinsmoor, Robert // Countdown;Winter95, Vol. 16 Issue 1, p22 

    Reports on a study by Aldo Rossini of the University of Massachusetts on how the programming of the immune system breaks down in diabetes and how it can be reprogrammed to tolerate transplanted beta cells. Attack on insulin-producing beta cells of the pancreas by body's own immune system;...

  • Immunopathogenesis of islet transplantation in IDDM. Dinsmoor, Robert // Countdown;Winter95, Vol. 16 Issue 1, p24 

    Examines the cells of the immune system responsible for destroying beta cells. Study by Alexander Rabinovitch of the University of Alberta; Isolation of proteins produced by certain immune cells; Isolation of bacterial protein extracts that protect transplanted islets from rejection in diabetic...

  • Proteome analysis -- A novel approach to understand the pathogenesis of Type 1 diabetes mellitus. Karlsen, Allan E.; Sparre, Thomas; Nielsen, Karin; Nerup, Jørn; Pociot, Flemming // Disease Markers;2001, Vol. 17 Issue 4, p205 

    Type 1 (insulin-dependent) diabetes mellitus (T1DM) is associated with a specific destruction of the insulin-producing beta-cells in the islets of Langerhans. Several factors, e.g. genetic, environmental and immunologial, may be involved in the etiology and pathogenesis of T1DM. Autoreactive T-...

  • Looking at beta cells in the heart of Uppland.  // Countdown;Winter2001, Vol. 22 Issue 1, p24 

    Reports the study of pancreatic insulin-producing beta cells related to diabetes research in Uppsala University in Sweden. Investigation of the mechanisms of beta cell destruction; Improvement of the success of islet cell transplantion; Formation of the microdialysis project.

  • Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats. O'Brien, B.A.; Fieldus, W.E.; Field, C.J.; Finegood, D.T. // Cell Death & Differentiation;Apr2002, Vol. 9 Issue 4, p457 

    The kinetics of β-cell death in neonatal diabetes-prone (BBdp) and diabetes-resistant (BBdr) BioBreeding rats was investigated using both direct (histochemical) and indirect (mathematical modelling) techniques. In both BBdp and BBdr rats, the incidence of TUNEL positive β-cells increased...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics